<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9802571</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20730</journal-id>
<journal-id journal-id-type="nlm-ta">Mol Cell</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Cell</journal-id>
<journal-title-group>
<journal-title>Molecular cell</journal-title>
</journal-title-group>
<issn pub-type="ppub">1097-2765</issn>
<issn pub-type="epub">1097-4164</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31375262</article-id>
<article-id pub-id-type="pmc">7291823</article-id>
<article-id pub-id-type="doi">10.1016/j.molcel.2019.06.024</article-id>
<article-id pub-id-type="manuscript">NIHMS1533064</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Heterozygous mutations in SMARCA2 reprogram the enhancer landscape by global retargeting of SMARCA4</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Gao</surname>
<given-names>Fangjian</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Elliott</surname>
<given-names>Nicholas J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ho</surname>
<given-names>Josephine</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sharp</surname>
<given-names>Alexzander</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shokhirev</surname>
<given-names>Maxim N.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hargreaves</surname>
<given-names>Diana C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Molecular and Cellular Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California 92037 USA</aff>
<aff id="A2"><label>2</label>University of California San Diego Biological Sciences Graduate Program, La Jolla, California 92037 USA</aff>
<aff id="A3"><label>3</label>Razavi Newman Integrative Genomics and Bioinformatics Core, Salk Institute for Biological Studies, La Jolla California 92037 USA</aff>
<aff id="A4"><label>4</label>Lead Contact</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1">AUTHOR CONTRIBUTIONS</p>
<p id="P2">Conceptualization: F.G. and D.C.H.; Methodology: F.G. and D.C.H.; Investigation: F.G. and N.E., J.H.; Formal Analysis: F.G., N.E., D.C.H.; Validation: A.S.; Writing-Original Draft: F.G. and D.C.H.; Writing-Review and Editing: F.G. and D.C.H.; Software: M.N.S.; Project Administration: D.C.H.; Funding Acquisition: F.G. and D.C.H.</p>
</fn>
<corresp id="CR1"><label>*</label>To whom correspondence and material requests should be addressed: <email>dhargreaves@salk.edu</email></corresp>
<fn fn-type="COI-statement" id="FN4">
<p id="P67">DECLARATION OF INTERESTS</p>
<p id="P68">The authors declare no competing interests.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>6</day>
<month>7</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>7</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<day>05</day>
<month>9</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>05</day>
<month>9</month>
<year>2020</year>
</pub-date>
<volume>75</volume>
<issue>5</issue>
<fpage>891</fpage>
<lpage>904.e7</lpage>
<!--elocation-id from pubmed: 10.1016/j.molcel.2019.06.024-->
<abstract id="ABS1">
<title>SUMMARY</title>
<p id="P3">Mammalian SWI/SNF complexes are multi-subunit chromatin remodeling complexes associated with an ATPase, either SMARCA4 or SMARCA2. Heterozygous mutations in the SMARCA2 ATPase cause Nicolaides-Baraitser Syndrome (NCBRS), an intellectual disability syndrome associated with delayed speech onset. We engineered human embryonic stem cells (hESCs) to carry NCBRS-associated heterozygous SMARCA2 K755R or R1159Q mutations. While SMARCA2 mutant hESCs were phenotypically normal, differentiation to neural progenitors cells (NPCs) was severely impaired. We find that SMARCA2 mutations cause enhancer reorganization with loss of SOX3-dependent neural enhancers and prominent emergence of astrocyte-specific <italic>de novo</italic> enhancers. Changes in chromatin accessibility at enhancers were associated with an increase in SMARCA2 binding and retargeting of SMARCA4. We show that AP-1 family member FRA2 is aberrantly overexpressed in SMARCA2 mutant NPCs, where it functions as a pioneer factor at <italic>de novo</italic> enhancers. Together, our results demonstrate SMARCA2 mutations cause impaired differentiation through enhancer reprogramming via inappropriate targeting of SMARCA4.</p>
</abstract>
<abstract abstract-type="graphical" id="ABS2">
<title>Graphical Abstract:</title>
<p id="P4">
<graphic orientation="portrait" position="anchor" xlink:href="nihms-1533064-f0001.jpg"></graphic>
</p>
<p id="P5"><bold>eTOC Blurb(</bold>An eTOC blurb should also be included that is no longer than 50 words describing the context and significance of the findings for the broader journal readership. When writing this paragraph, please target it to non-specialists by highlighting the major conceptual point of the paper in plain language, without extensive experimental detail. The blurb must be written in the third person and refer to “First Author et al.”<bold>):</bold></p>
<p id="P6">Mutations in subunits of the SWI/SNF complex cause developmental disorders associated with intellectual disability and speech delay. However, the mechanistic basis of disease is poorly understood. Gao et al. show that disease-associated SMARCA2 mutations lead to impaired neural differentiation due to changes in transcription factor expression that drive enhancer reprogramming.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>